Prior SARS-CoV-2 infection and COVID-19 vaccine effectiveness against outpatient illness during widespread circulation of SARS-CoV-2 Omicron variant, US Flu VE network.

Sara Y TartofFagen XieRuchi YadavKaren J WernliEmily T Martin Edward A BelongiaManjusha GaglaniRichard K ZimmermanH Keipp TalbotNatalie J Thornburg Brendan Flannerynull null

Published in: Influenza and other respiratory viruses (2023)

Three mRNA COVID-19 vaccine doses provided additional protection against SARS-CoV-2 Omicron variant-associated illness among previously infected participants.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
randomized controlled trial
systematic review
binding protein
network analysis